FDAnews
www.fdanews.com/articles/96349-symbollon-files-new-patent-application-covering-the-chronic-administration-of-iogen-to-women

Symbollon Files New Patent Application Covering the Chronic Administration of IoGen to Women

July 25, 2007

Symbollon Pharmaceuticals, Inc. announced that the company has filed a new patent application covering IoGen, its proprietary compound being evaluated for its ability to eliminate excess tissue growth in female reproductive organs.
Yahoo Finance